REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
06/27/2026
Back to search
Official data from USPTO
IMMUNONUTRIENT LABORATORIES
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
IMMUNONUTRIENT LABORATORIES
ST13
US500000086813782Class
40
Filing
86813782
Registration
5234065
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
06/27/2026
Trademark type
Word
Nice classes
40
Filing date
11/09/2015
Registration date
06/27/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/01/2023
Last transaction
06/27/2026
Responsible office
United States Patent and Trademark Office
Status code
701
Official register
Supplemental Register
First use anywhere
05/23/2008
First use in commerce
05/23/2008
Drawing code
4
Owner type
03
Owner location
Plymouth, MN, US
Examiner
LEIPZIG, MARC J
Law office
M60
Current location
TMO LAW OFFICE 115
Holders and representatives
Holders
Eniva USA Inc
Representatives
Eniva USA Inc
Technical classification
Nice Classes
Class 40
Vienna Codes
No Vienna codes available.
Goods and services
Class 40
Contract manufacturing in the field of Nutraceutical supplements and Health Care products; Manufacture of Nutraceuticalssupplements and Health Care products to order and/or specification of others; Research in the field of manufacturing processes; Technical support servicesproviding technical advice related to the manufacture of Nutraceuticalssupplements and Health Care products
Publications
History of USPTO decisions and trademark events.
25 publications found
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
11/01/2023
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
11/01/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/27/2023
ES8R
TEAS SECTION 8 RECEIVED
06/23/2023
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
06/27/2022
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
06/27/2017
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
05/22/2017
ALIE
ASSIGNED TO LIE
05/10/2017
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
04/13/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/27/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/27/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/27/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/25/2016
GNRT
NON-FINAL ACTION E-MAILED
09/25/2016
CNRT
NON-FINAL ACTION WRITTEN
09/25/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/01/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/31/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/31/2016
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/09/2016
GNRT
NON-FINAL ACTION E-MAILED
03/09/2016
CNRT
NON-FINAL ACTION WRITTEN
03/09/2016
DOCK
ASSIGNED TO EXAMINER
03/02/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/13/2015
NWAP
NEW APPLICATION ENTERED
11/12/2015
Continuous trademark protection
Get notified about every new filing that threatens IMMUNONUTRIENT LABORATORIES or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.